Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iradimed (IRMD) Other Operating Expenses (2016 - 2026)

Iradimed has reported Other Operating Expenses over the past 14 years, most recently at $4.1 million for Q1 2026.

  • Quarterly Other Operating Expenses fell 2.97% to $4.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Mar 2026, up 8.34% year-over-year, with the annual reading at $203000.0 for FY2025, 5175.0% up from the prior year.
  • Other Operating Expenses was $4.1 million for Q1 2026 at Iradimed, down from $4.6 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $4.6 million in Q3 2025 and troughed at $793716.0 in Q1 2023.
  • The 5-year median for Other Operating Expenses is $3.7 million (2022), against an average of $3.5 million.
  • Year-over-year, Other Operating Expenses plummeted 74.14% in 2023 and then skyrocketed 382.18% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $3.7 million in 2022, then decreased by 9.16% to $3.3 million in 2023, then skyrocketed by 35.68% to $4.5 million in 2024, then increased by 1.91% to $4.6 million in 2025, then dropped by 11.98% to $4.1 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Other Operating Expenses are $4.1 million (Q1 2026), $4.6 million (Q4 2025), and $4.6 million (Q3 2025).